Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.62 |
| ▸ | DGKA | P23743 | 1/20 | 0.62 |
| ▸ | HTR2C | P28335 | 1/20 | 0.59 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.54 |
| ▸ | RAD52 | P43351 | 1/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.53 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.53 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.53 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.53 |
| ▸ | FAAH | O00519 | 1/20 | 0.51 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.51 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | PAM | P19021 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL385290 | 1.00 | NAAA (0.62) | NAAADGKAHTR2CPLA2G4BRAD52 | |
| SCHEMBL6839694 | 1.00 | NAAA (0.62) | NAAADGKAHTR2CPLA2G4BRAD52 | |
| SCHEMBL4275603 | 1.00 | NAAA (0.62) | NAAADGKAHTR2CPLA2G4BRAD52 | |
| SCHEMBL16267108 | 1.00 | NAAA (0.62) | NAAADGKAHTR2CPLA2G4BRAD52 | |
| SCHEMBL74624 | 1.00 | NAAA (0.62) | NAAADGKAHTR2CPLA2G4BRAD52 | |
| SCHEMBL21753922 | 1.00 | NAAA (0.62) | NAAADGKAHTR2CPLA2G4BRAD52 | |
| SCHEMBL5014079 | 1.00 | NAAA (0.62) | NAAADGKAHTR2CPLA2G4BRAD52 | |
| SCHEMBL112309 | 1.00 | NAAA (0.62) | NAAADGKAHTR2CPLA2G4BRAD52 | |
| SCHEMBL5012945 | 1.00 | NAAA (0.62) | NAAADGKAHTR2CPLA2G4BRAD52 | |
| SCHEMBL5016250 | 1.00 | NAAA (0.62) | NAAADGKAHTR2CPLA2G4BRAD52 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119159877-A | Flame-retardant waterproof asphalt coiled material and preparation method thereof | 河北宇阳泽丽防水材料有限公司 | 2024-12-20 | — | — | CN | claimed |
| EP-2606164-A1 | ELECTROLYTE AND PROCESS FOR THE DEPOSITION OF COPPER-TIN ALLOY LAYERS | Umicore Galvanotechnik GmbH (DE) | 2013-06-26 | — | — | EP | claimed |
| US-20130140185-A1 | ELECTROLYTE AND PROCESS FOR THE DEPOSITION OF COPPER-TIN ALLOY LAYERS | UMICORE GALVANOTECHNIK GMBH (DE) | 2013-06-06 | — | — | US | claimed |
| CN-102802605-A | Stable lipid formulations of apoptosis promoters | ABBOTT LAB | 2012-11-28 | — | — | CN | claimed |
| EP-2424499-A1 | STABILIZED LIPID FORMULATION OF APOPTOSIS PROMOTER | Abbott Laboratories (US) | 2012-03-07 | — | — | EP | claimed |
| WO-2012022689-A1 | ELECTROLYTE AND PROCESS FOR THE DEPOSITION OF COPPER-TIN ALLOY LAYERS | UMICORE GALVANOTECHNIK GMBH (DE) | 2012-02-23 | — | — | WO | claimed |
| US-20100278905-A1 | STABILIZED LIPID FORMULATION OF APOPTOSIS PROMOTER | ABBVIE INC. | 2010-11-04 | — | — | US | claimed |
| WO-2010127193-A1 | STABILIZED LIPID FORMULATION OF APOPTOSIS PROMOTER | ABBOTT LABORATORIES (US) | 2010-11-04 | — | — | WO | claimed |
| CN-100451041-C | (Melhy) propenyl series crosslink micro particles and its producing process | NIPPON CATALYTIC CHEM IND (JP) | 2009-01-14 | — | — | CN | claimed |
| CN-1408739-A | (Melhy) propenyl series crosslink micro particles and its producing process | NIPPON CATALYTIC CHEM IND (JP) | 2003-04-09 | — | — | CN | claimed |
| US-4013618-A | NITROGEN-CONTAINING STABILIZER | TOYOBO CO., LTD. (JA) | 1977-03-22 | — | — | US | claimed |
| JP-3243649-A | — | — | None | — | — | JP | disclosed |
| CN-119998518-A | Treatment agent for synthetic fibers and synthetic fibers | 竹本油脂株式会社 | 2025-05-13 | — | — | CN | disclosed |
| CN-119768582-A | Treatment agent for synthetic fibers and synthetic fibers | 竹本油脂株式会社 | 2025-04-04 | — | — | CN | disclosed |
| CN-119343385-A | Free radical polymerizable composition and polymer thereof | 株式会社日本触媒 | 2025-01-21 | — | — | CN | disclosed |
| US-4977193-A | FOAMING IN PRESENCE OF ORGANOTIN MERCAPTO ACID ESTER | WITCO CORPORATION (US) | 1990-12-11 | — | — | US | disclosed |
| US-4863982-A | HEAT, LIGHT AND OXIDATION STABILIZERS | CIBA-GEIGY CORPORATION (US) | 1989-09-05 | — | — | US | disclosed |
| US-4699939-A | OXIDATION RESISTANCE, PHOTOSTABILITY | CIBA-GEIGY CORPORATION (US) | 1987-10-13 | — | — | US | disclosed |
| US-4113488-A | PHENOLIC COMPOUND AND SYNERGISTIC SULFIDE OR SULFOXIDE | FUJI PHOTO FILM CO., LTD. (JP) | 1978-09-12 | — | — | US | disclosed |
| US-4013618-A | NITROGEN-CONTAINING STABILIZER | TOYOBO CO., LTD. (JA) | 1977-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100278905-A1 | STABILIZED LIPID FORMULATION OF APOPTOSIS PROMOTER | BCL2, BAX, BCOR | NAAA 4513/4885DGKA 2084/4885HTR2C 2559/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.